Addex to present at bio€quity europe 2024

Geneva, switzerland, may 8, 2024 - addex therapeutics (six and nasdaq: adxn), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that ceo, tim dyer, will present at the bio€quity europe 2024 conference taking place may 12 - 14, 2024 at the kursaal congress center in san sebastiÁn, spain.

ADXN Ratings Summary

ADXN Quant Ranking